A detailed history of Accredited Investors Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Accredited Investors Inc. holds 967 shares of BDX stock, worth $225,881. This represents 0.01% of its overall portfolio holdings.

Number of Shares
967
Previous 901 7.33%
Holding current value
$225,881
Previous $222,000 1.35%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$225.07 - $246.17 $14,854 - $16,247
66 Added 7.33%
967 $225,000
Q2 2023

Aug 03, 2023

SELL
$238.39 - $265.32 $190,712 - $212,256
-800 Reduced 47.03%
901 $237,000
Q4 2022

Feb 07, 2023

SELL
$218.29 - $256.91 $436 - $513
-2 Reduced 0.12%
1,701 $432,000
Q3 2022

Nov 08, 2022

BUY
$51.03 - $264.23 $153 - $792
3 Added 0.18%
1,703 $379,000
Q2 2022

Jul 21, 2022

SELL
$234.74 - $275.42 $938 - $1,101
-4 Reduced 0.23%
1,700 $419,000
Q1 2022

May 06, 2022

BUY
$243.64 - $270.48 $974 - $1,081
4 Added 0.24%
1,704 $453,000
Q4 2021

Jan 31, 2022

SELL
$230.08 - $250.94 $10,353 - $11,292
-45 Reduced 2.58%
1,700 $428,000
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $19,781 - $21,799
85 Added 5.12%
1,745 $429,000
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $230 - $256
-1 Reduced 0.06%
1,660 $420,000
Q4 2018

Feb 13, 2019

BUY
$204.73 - $257.93 $176,067 - $221,819
860 Added 107.37%
1,661 $374,000
Q3 2018

Oct 23, 2018

SELL
$233.07 - $256.0 $14,450 - $15,872
-62 Reduced 7.18%
801 $209,000
Q2 2018

Jul 31, 2018

SELL
$208.1 - $233.85 $26,636 - $29,932
-128 Reduced 12.92%
863 $207,000
Q1 2018

Apr 18, 2018

BUY
$205.46 - $240.27 $203,610 - $238,107
991 New
991 $215,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.6B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Accredited Investors Inc. Portfolio

Follow Accredited Investors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accredited Investors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Accredited Investors Inc. with notifications on news.